KITS — Kits Eyecare Income Statement
0.000.00%
Last trade - 00:00
- CA$181.72m
- CA$181.08m
- CA$120.51m
- 88
- 34
- 79
- 75
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 36.9 | 75.2 | 82.4 | 91.6 | 121 |
Cost of Revenue | |||||
Gross Profit | 10.8 | 21.4 | 20.9 | 29.2 | 40.8 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 34.9 | 74.9 | 99.8 | 96 | 122 |
Operating Profit | 2.02 | 0.3 | -17.4 | -4.35 | -1.92 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 0.09 | -7.09 | -18.8 | -5.88 | -2.89 |
Provision for Income Taxes | |||||
Net Income After Taxes | 0.053 | -6.58 | -14.6 | -4.55 | -2.21 |
Net Income Before Extraordinary Items | |||||
Net Income | 0.053 | -6.58 | -14.6 | -4.55 | -2.21 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 0.053 | -6.58 | -14.6 | -4.55 | -2.21 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.007 | -0.197 | -0.443 | -0.146 | -0.08 |
Dividends per Share |